600587.SH
新华医疗
SSE · Healthcare · Medical - Devices · CN
CNY 12.23
−1.45%Year over year
Reported trailing growth
- Revenue
- -1.2%
- EBITDA
- —
- EBIT
- -27.0%
- EPS
- -33.0%
- Free cash flow
- —
- Operating cash flow
- +86.0%
Forward estimates
Based on analyst estimates
- Revenue
- -45.6%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +1.6%
- EBITDA
- +1.1%
- EBIT
- +0.3%
- Net income
- +1.7%
- EPS
- -10.9%
- Free cash flow
- +31.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026